TABLE 2.
Ca2+ mobilization | IP1 accumulation | ERK1/2 phosphorylation | Receptor internalization | |||||
---|---|---|---|---|---|---|---|---|
pKB | n | pKB | n | pKB | n | pKB | n | |
AZD2066 | 6.49 ± 0.15 | 3 | 7.82 ± 0.12 | 4 | 7.34 ± 0.14 | 3 | 6.75 ± 0.14 | 3 |
Basimglurant | 8.33 ± 0.15 | 3 | 8.69 ± 0.13 | 4 | 8.66 ± 0.15 | 4 | 8.06 ± 0.12a | 3 |
Dipraglurant | 5.83 ± 0.15 | 3 | 6.50 ± 0.12b | 4 | 6.67 ± 0.14b | 3 | 7.17 ± 0.13a,b | 3 |
F169521 | 6.09 ± 0.15 | 3 | 6.19 ± 0.15 | 4 | 6.69 ± 0.14 | 3 | 6.24 ± 0.12 | 3 |
F1699611 | 6.25 ± 0.15 | 3 | 7.08 ± 0.12b | 4 | 6.82 ± 0.14 | 3 | 6.71 ± 0.13 | 3 |
Mavoglurant | 6.49 ± 0.15 | 3 | 7.55 ± 0.11b | 4 | 7.30 ± 0.14b | 3 | 7.04 ± 0.13 | 3 |
Remeglurant | 6.09 ± 0.15 | 3 | 7.12 ± 0.12b | 4 | 7.09 ± 0.14b | 3 | 6.79 ± 0.13b | 3 |
(RS)-remeglurant | 5.80 ± 0.15 | 3 | 6.54 ± 0.13b | 4 | 7.04 ± 0.13b | 3 | 6.33 ± 0.13c | 3 |
STX107 | 6.97 ± 0.15 | 3 | 7.46 ± 0.11 | 4 | 7.52 ± 0.14 | 3 | 7.14 ± 0.19 | 3 |
Significantly different from estimate derived from IP1 accumulation assays, P < 0.05, one-way ANOVA with Tukey’s multiple comparisons post-test.
Significantly different from estimate derived from Ca2+ mobilization assays, P < 0.05, one-way ANOVA with Tukey’s multiple comparisons post-test.
Significantly different from estimate derived from ERK1/2 phosphorylation assays, P < 0.05, one-way ANOVA with Tukey’s multiple comparisons post-test.